Description
Taylor & Francis Drug-Induced Movement Disorders 2004 Edition by Kapil D. Sethi
Drug-Induced Movement Disorders rigorously analyzes established and emerging facts surrounding drug-induced dystonia, dyskinesia, akathisia, parkinsonism, and other acute and tardive movement disorders liable to result from medicinal use of dopamine blocking agents, antidepressants, levodopa, anticonvulsants, and other drugs-providing professionals effective tools for predicting, identifying, and proactively managing these often treatable, and frequently preventable, conditions. Table of contents :- Concepts, Principles, and Rationale for Optimizing the Institutional Use of Antimicrobial Agents How to Create a Therapeutics Committee That is Scientifically and Economically Sound Richard Quintiliani and Robert Quercia The Public Health Action Plan to Combat Antimicrobial Resistance and the Prevention of Antimicrobial Resistance in Healthcare Settings J. Todd Weber Why Appropriate Antibiotic Selection is Important: Focus on Outcomes Marin H. Kollef Role of Microbiologic Surveillance Data in Selecting Optimal Antimicrobial Therapy Mike Dudley Antimicrobial Pharmacodynamics for the Clinician David Andes and Bill Craig Role of Adverse Events and Medical Errors in the Formulary Decision Process David Nix Basic Pharmacoeconomics for the Hospital Decision Maker Mary Anne McCollum Applied Strategies, Programs, and Guidelines: Optimizing the Institutional Use of Antimicrobial Agents The Role of Infection Control and Hospital Epidemiology in the Optimization of Antibiotic Use August J. Valenti Antimicrobial Stewardship Initiatives: A Programmatic Approach to Optimizing Antimicrobial Use Gilles Fraser, Patricia Stogsdill, and Robert C. Owens, Jr. Role of Computer-Assisted Programs in Optimizing the Use of Antimicrobial Agents John Burke Application of Pharmacodynamic Principles: From Theory to Practice Joseph L. Kuti and David Nicolau Impacting Institutional Antimicrobial Use: Focus on Resistance Profiles and Bug-Drug Specific Relationships Robert C. Owens, Jr. and Paul G. Ambrose Early Discharge Strategies: Role of Transitional Therapy Programs Julio Ramirez.